- Current report filing (8-K)
March 03 2010 - 12:42PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): March 1, 2010
SHENGTAI
PHARMACEUTICAL, INC.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of
incorporation)
|
000-51312
(Commission
File
Number)
|
54-2155579
(IRS
Employer
Identification
No.)
|
Changda
Road East
Development
District, Changle County
Shandong, PRC
(Address
of principal executive offices)
|
262400
(Zip
Code)
|
Registrant’s
telephone number, including area code:
011-86-536-218-2777
Copies to:
Benjamin
Tan, Esq.
Sichenzia
Ross Friedman Ference LLP
61
Broadway, 32 Floor
New York,
New York 10006
Phone:
(212) 930-9700
Fax:
(212) 930-9725
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
|
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement communications
pursuant t
o Rule
14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.02
|
Departure
of Directors or Principal Officers; Election of Directors; Appointment of
Principal Officers
|
On March 1, 2010, Mr. Yongqiang Wang
resigned as our Chief Financial Officer. On the same date, we entered into an
employment agreement with Mr. Hu Ye to appoint Mr. Ye as our new Chief Financial
Officer. The employment agreement was ratified by our board of directors on
March 3, 2010.
Mr. Ye,
48, was the CFO of China Shen Zhou Mining & Resources, Inc. (AMEX: SHZ) from
June 2008 to March 2009 and the CFO of Si Mei Te Food Ltd. (OTCBB: CADQ.OB) from
May 2009 to September 2009. He worked in China as the CFO of Odysys
International Ltd. from December 2003 to March 2006, CFO of BOCO Enterprises
Ltd. from March 2006 to March 2007 and from December 2007 to May 2008, and CFO
of EMarket Holding Group Corp. from March 2007 to November 2007. From
January 2002 to September 2003 Mr. Ye was a consultant at Securitization
Finance, CIT Group, Inc. in Canada. From June 1999 to March 2001 Mr. Ye was an
Assistant Vice-President in Finance, Corporate and Institutional Client Group of
Merrill Lynch Canada. From January 1990 to June 1999, Mr. Ye worked as a
financial analyst of Finance and Tax, and a Financial Control Administrator at
Mackenzie Financial Corporation in Canada.
Mr. Ye
received his degree of Master of Arts in Economics from University of Toronto,
Canada in 1989 and a Bachelor of Science in Electrical Engineering from Huazhong
University of Science and Technology, China in 1984. Mr. Ye has been a Certified
General Accountant (CGA) of Canada since 1998.
Mr. Ye
has been serving as a Non-Executive Board Member of Beijing Heidrick &
Struggles International Management Consulting Co. Ltd. since July 2006 and as a
Non-Executive Board Member of CIC Mining Resources Ltd. (CNQ:C.RRR; FSE:31C)
since February 2009.
There is
no family relationship between Mr. Ye and any of our other officers and
directors. Except for the employment agreement described below, Mr. Ye has not
had any transaction with us since the beginning of our last fiscal
year.
Mr. Ye’s
term of office as our Chief Financial Officer is three years. Mr. Ye’s
compensation as our Chief Financial Officer is set forth in an employment
agreement between Mr. Ye and us dated March 1, 2010. Under that
agreement, Mr. Ye is to receive compensation consisting of the following: (i) an
annual salary of RMB 1,000,000 (approximately $146,494) Yuan for the first year,
RMB 1,200,000 Yuan (approximately $175,793) for the second year, and RMB
1,500,000 Yuan (approximately $ 219,741) for the third year, (ii) an option to
purchase 300,000 shares of common stock of the Company at the exercise price of
$2.60 per share, vesting in equal installments on each of the first three
anniversaries of the grant date, subject to Mr. Ye’s employment with the
Company, and (iii) medical and dental insurance.
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
SHENGTAI
PHARMACEUTICAL, INC.
|
|
|
|
|
Dated:
March 3, 2010
|
|
|
By:
/s/ Qingtai
Liu
|
|
Name:
Qingtai Liu
|
|
Title:
Chief Executive
Officer
|
Shengtai Pharmaceutical (GM) (USOTC:SGTI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Shengtai Pharmaceutical (GM) (USOTC:SGTI)
Historical Stock Chart
From Jul 2023 to Jul 2024